NICOLE CRAWFORD: Open Payments
NPI 1376197335 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,534 in 192 payments from 17 companies in 2025. Trend: 2023 $4,757 · 2024 $3,605 · 2025 $4,534
Food & beverage: $4,500Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 36 | $1,416 |
| GENZYME CORPORATION | 19 | $527 |
| GlaxoSmithKline, LLC. | 38 | $481 |
| Verona Pharma, Inc. | 31 | $474 |
| Regeneron Healthcare Solutions, Inc. | 9 | $295 |
| Insmed, Inc. | 10 | $231 |
| Grifols USA, LLC | 10 | $206 |
| Amgen Inc. | 11 | $186 |
| Viatris Specialty LLC | 5 | $112 |
| PFIZER INC. | 1 | $104 |
Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, BREZTRI, NUCALA, AIRSUPRA, Arikayce, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
